4
Changes in Ownership
Eloxx Pharmaceuticals, Inc. Filed Acc 0001104659-25-006784
Director acquired 30,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Aggarwal Sumit · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-01-24 | Exercise or conversion : show line 1 in the form | +30,000 | 199,930 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-01-24 | Exercise or conversion : show line 2 in the form Restricted Stock Units | −30,000 | 30,000 | D |
Loading xslF345X05/tm254730-4_4seq1.xml…